Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide.

Autor: Freyer, Craig W.1 (AUTHOR), Carulli, Alison1 (AUTHOR), Gier, Shannon2 (AUTHOR), Ganetsky, Alex1 (AUTHOR), Timlin, Colleen1 (AUTHOR), Schuster, Mindy3 (AUTHOR), Babushok, Daria2 (AUTHOR), Frey, Noelle V.2 (AUTHOR), Gill, Saar I.2 (AUTHOR), Hexner, Elizabeth O.2 (AUTHOR), Luger, Selina M.2 (AUTHOR), Mangan, James K.2 (AUTHOR), Martin, Mary Ellen2 (AUTHOR), McCurdy, Shannon R.2 (AUTHOR), Perl, Alexander E.2 (AUTHOR), Porter, David L.2 (AUTHOR), Pratz, Keith2 (AUTHOR), Smith, Jacqueline2 (AUTHOR), Stadtmauer, Edward A.2 (AUTHOR), Loren, Alison W.2 (AUTHOR)
Zdroj: Leukemia & Lymphoma. Aug2022, Vol. 63 Issue 8, p1925-1933. 9p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje